Enclomiphene Citrate Sleep Impact and Optimization

Print or save as PDF

Does enclomiphene affect sleep?

Sleep is not a documented outcome for enclomiphene. Enclomiphene is an oral selective estrogen receptor modulator that blocks estrogen receptors in the pituitary, raising LH and FSH and increasing testosterone production [1]. The phase 3 program measured testosterone, LH, FSH and sperm counts [1]. The sponsor announced a complete response from FDA in 2015, which FDA summarized as saying the phase 3 study design was not adequate to demonstrate clinical benefit [1]. EMA's 2018 refusal was based on four main studies in 588 patients; the studies showed higher testosterone but did not look at whether symptoms improved, and EMA cited a risk of venous thromboembolism [2].

What side effects are reported?

In the phase 3 and EMA data, the most frequent side effects were headache, hot flushes, nausea and muscle spasm [3]. Reasons for stopping included blurred vision, muscle spasm, headache and aggression [3]. In ZA-302, headache was reported by 7 of 112 men on 12.5 mg and 1 of 47 on placebo; nausea by 4 of 112 and 3 of 47 [3].

The only FDA-approved label in this drug family is for clomiphene citrate, the mixture of enclomiphene and zuclomiphene, and it covers ovulatory dysfunction in women desiring pregnancy [1][5]. That label lists insomnia among adverse events reported in fewer than 1% of patients in clinical trials [5]. It is not an enclomiphene label, and its rates cannot be applied to enclomiphene alone [1][5].

Is there a best time of day to take it for sleep?

Enclomiphene has no FDA-approved dose [1]. The doses studied were 6.25, 12.5 and 25 mg once daily [4]; phase 3 protocols used 12.5 mg daily with up-titration to 25 mg at week 6 if morning testosterone stayed below 300 ng/dL [6]. Enclomiphene is absorbed rapidly, with peak levels 2 to 3 hours after a dose and a half-life of about 10 hours [1]. Those pharmacokinetic facts describe drug levels. They do not establish a morning or evening dosing schedule for sleep.

Is enclomiphene approved, and what safety data exist?

Enclomiphene is not FDA-approved [1]. A 2026 British Society of Sexual Medicine position statement says it is not approved by FDA or EMA, the manufacturer discontinued development in 2021, and long-term efficacy and safety data are lacking [7]. FDA listed cardiac and thromboembolic events, raised estradiol, raised PSA and raised hematocrit among safety concerns, and noted no long-term safety data [1].